Novo Nordisk A/S (NOVO-B.CO)
DKK 771.6
(0.22%)
DKK 771.6
(0.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 108.9 Billion | 78.88 Billion | 55 Billion | 51.95 Billion | 46.78 Billion | 44.61 Billion |
| Net Income | 83.68 Billion | 55.52 Billion | 47.75 Billion | 42.13 Billion | 38.95 Billion | 38.62 Billion |
| Depreciation & Amortization | 9.41 Billion | 7.36 Billion | 6.02 Billion | 5.75 Billion | 5.66 Billion | 3.92 Billion |
| Deferred income taxes | 20.99 Billion | 13.53 Billion | 11.32 Billion | 10.99 Billion | 9.6 Billion | 8.98 Billion |
| Stock-based compensation | 2.14 Billion | 1.53 Billion | 1.04 Billion | 823 Million | 363 Million | 414 Million |
| Change in working capital | -12.24 Billion | -5.33 Billion | -8.65 Billion | -4.35 Billion | -3.38 Billion | -3.37 Billion |
| Other non-cash items | 4.91 Billion | 6.26 Billion | -2.48 Billion | -3.4 Billion | -4.4 Billion | -3.96 Billion |
| Investing Cash Flow | -43.89 Billion | -24.91 Billion | -31.6 Billion | -22.43 Billion | -11.5 Billion | -12.08 Billion |
| Investments in PPE | -38.89 Billion | -14.75 Billion | -7.38 Billion | -22.08 Billion | -11.23 Billion | -12.41 Billion |
| Acquisitions | 13.09 Billion | -7.07 Billion | -18.28 Billion | -392 Million | -100 Million | 368 Million |
| Investment purchases | -13.28 Billion | -9.73 Billion | -7.11 Billion | 16.25 Billion | -350 Million | -248 Million |
| Sales/Maturities of investments | 8.29 Billion | 6.64 Billion | 1.17 Billion | 12 Million | 148 Million | 178 Million |
| Other Investing Activities | -13.09 Billion | -5.69 Billion | 4 Million | -16.23 Billion | 24 Million | 32 Million |
| Financing Cash Flow | -63.15 Billion | -51.79 Billion | -25.49 Billion | -32.24 Billion | -35.48 Billion | -34.52 Billion |
| Debt repayment | -1.46 Billion | -13.62 Billion | -6.68 Billion | -950 Million | -741 Million | -94 Million |
| Dividends payments | -31.76 Billion | -25.3 Billion | -21.51 Billion | -20.12 Billion | -19.4 Billion | -19.04 Billion |
| Common Stock Repurchased | -29.92 Billion | -24.08 Billion | -19.44 Billion | -16.85 Billion | -15.33 Billion | -15.56 Billion |
| Common Stock Issuance | - | - | - | - | 16.07 Billion | - |
| Other Financing Activities | -1.44 Billion | 11.21 Billion | 22.16 Billion | 5.68 Billion | -16.07 Billion | 94 Million |
| Accounts receivables | -14.21 Billion | -9.91 Billion | -12.9 Billion | -2.82 Billion | -2.12 Billion | -2.62 Billion |
| Accounts payables | 10.01 Billion | 6.71 Billion | 3.15 Billion | -641 Million | -398 Million | 1.14 Billion |
| Inventory | -7.42 Billion | -4.76 Billion | -1.08 Billion | -895 Million | -1.3 Billion | -963 Million |
| Other working capital | -631 Million | 2.63 Billion | 2.18 Billion | 5 Million | 441 Million | -932 Million |
| Cash at beginning of period | 12.65 Billion | 10.71 Billion | 12.22 Billion | 15.41 Billion | 15.62 Billion | 17.15 Billion |
| Cash at end of period | 14.39 Billion | 12.65 Billion | 10.71 Billion | 12.22 Billion | 15.41 Billion | 15.62 Billion |
| Capital Expenditure | -38.89 Billion | -14.75 Billion | -7.38 Billion | -22.08 Billion | -11.23 Billion | -12.41 Billion |
| Effect of forex changes on cash | -119 Million | -238 Million | 591 Million | -456 Million | -7 Million | 44 Million |
| Net cash flow / Change in cash | 1.73 Billion | 1.93 Billion | -1.5 Billion | -3.18 Billion | -218 Million | -1.52 Billion |
| Free Cash Flow | 70.01 Billion | 64.13 Billion | 47.61 Billion | 29.87 Billion | 35.55 Billion | 32.2 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.05 Billion | 25.4 Billion | 83.68 Billion | 21.96 Billion | 22.47 Billion | 19.42 Billion |
| Depreciation & Amortization | 8.84 Billion | 2.91 Billion | 9.41 Billion | 2.99 Billion | 2.52 Billion | 2.17 Billion |
| Deferred income taxes | 5.28 Billion | 6.51 Billion | 20.99 Billion | 5.65 Billion | 5.58 Billion | 4.82 Billion |
| Stock-based compensation | - | - | 2.14 Billion | 2.14 Billion | - | - |
| Change in working capital | 9.1 Billion | -8.85 Billion | -12.24 Billion | -9.68 Billion | 11.66 Billion | -4.01 Billion |
| Other non-cash items | 30.19 Billion | 673 Million | 4.91 Billion | -34.95 Billion | 1.98 Billion | 10.7 Billion |
| Investing Cash Flow | -20.73 Billion | 3.95 Billion | -43.89 Billion | -14.71 Billion | -13.24 Billion | -9.28 Billion |
| Investments in PPE | -13.23 Billion | -9 Billion | -38.89 Billion | -16.43 Billion | -10.62 Billion | -7.03 Billion |
| Acquisitions | -668 Million | - | 13.09 Billion | 7.02 Billion | 4.79 Billion | 1.15 Billion |
| Investment purchases | -9.86 Billion | -1.16 Billion | -13.28 Billion | -948 Million | -4.83 Billion | -5.14 Billion |
| Sales/Maturities of investments | 3.04 Billion | 14.12 Billion | 8.29 Billion | 2.66 Billion | 2.21 Billion | 2.89 Billion |
| Other Investing Activities | -9.59 Billion | 12.43 Billion | -13.09 Billion | -7.02 Billion | -4.79 Billion | -1.15 Billion |
| Financing Cash Flow | 16.68 Billion | -26.38 Billion | -63.15 Billion | -10.11 Billion | -19.83 Billion | -12.58 Billion |
| Debt repayment | -5.05 Billion | -317 Million | -1.46 Billion | -355 Million | -261 Million | -373 Million |
| Dividends payments | - | -28.55 Billion | -31.76 Billion | - | -13.43 Billion | - |
| Common Stock Repurchased | -7.44 Billion | -2.83 Billion | -29.92 Billion | -9.76 Billion | -6.14 Billion | -8.82 Billion |
| Common Stock Issuance | 34.51 Billion | - | - | - | 6.4 Billion | - |
| Other Financing Activities | -5.32 Billion | 5.32 Billion | - | - | -6.4 Billion | -3.39 Billion |
| Accounts receivables | - | - | -14.21 Billion | -14.21 Billion | - | - |
| Accounts payables | - | - | 10.01 Billion | - | - | - |
| Inventory | - | - | -7.42 Billion | -7.42 Billion | - | - |
| Other working capital | 9.1 Billion | -8.85 Billion | -631 Million | 1.93 Billion | 11.66 Billion | -4.01 Billion |
| Cash at beginning of period | 6.32 Billion | 14.39 Billion | 12.65 Billion | 29.88 Billion | 21.57 Billion | 14.93 Billion |
| Cash at end of period | 52.82 Billion | 6.32 Billion | 14.39 Billion | 14.39 Billion | 29.88 Billion | 21.57 Billion |
| Capital Expenditure | -13.23 Billion | -9 Billion | -38.89 Billion | -16.43 Billion | -10.62 Billion | -7.03 Billion |
| Effect of forex changes on cash | 42 Million | 44 Million | -119 Million | -209 Million | 418 Million | -65 Million |
| Net cash flow / Change in cash | 46.49 Billion | -8.06 Billion | 1.73 Billion | -15.49 Billion | 8.3 Billion | 6.63 Billion |
| Free Cash Flow | 37.26 Billion | 5.3 Billion | 70.01 Billion | -6.88 Billion | 30.34 Billion | 21.54 Billion |
SIMBHALS
5753
0HJO
CTXR
DUERF
OKEPF